Thank you!

The kick-off event of our Artiplus Expert Panel on September 9th, 2024, at the IMO, Barcelona, was amazing. We would like to thank all attendees for your presence, lively discussions, feedback and talks. To us, this evening marks the start of something special.

Did you miss this event? Or just want to relive it? Below you will find a recap and the full recording of the evening.

What the experts say

ESCRS_IMO_Guell

Extremely consistent

Prof. Dr. José Güell

"The results from the clinical study for uncorrected distance, intermediate and near visual acuity were extraordinary good. In my experience with Artiplus, the results have been extremely consistent."

Dr. Khoramnia

A great advantage is the reversible procedure

Prof. Dr. Ramin Khoramnia

"I'm doing, and that's a trend in my country, less laser surgery every year and we're doing more phakic lenses, because the results are so consistent and we have the advantage of reversibility."

ESCRS 2024_Im

Patients enjoy the result

Dr. Chan Young Im

"Artiplus is already available in South-Korea. I made some surgeries with Artiplus on pseudophakic and all the patients enjoyed the result. The procedure is in these cases easier, because you have plenty of room on the anterior chamber. Feel free to start with Artiplus!"

ESCRS 2024_Cezón2

Perfect centration

Dr. Julián Cezón

"The issue with posterior phakic IOLs is the centration; none of them are centered. With Artiplus you can perfectly center the lens."

Video Artiplus Expert Panel

Our key take-outs

MarketArtiplus IOL

  • Myopia and Presbyopia are huge challenges.
  • In 2050 60% of the population will be myopic.
  • 1.8 biljon presbyopes worldwide - 64 milion in Europe only.
  • Results of current presbyopia solutions in the market are not sufficient or consistent.

Clinical results Artiplus

  • 1 year follow-up data available of a international multicentered clinical trial;
  • Visual acuity extraordinary good at all distances.
  • Defocus curve results show the advantage of patients using residual accommodation.

Subjective feedback patients

  • Patients satisfaction is up to 98%.
  • No issues with visual artifacts like dysphotophias.

Long-term safety

  • Artiplus is built on the trusted and known Artiflex platform. Many papers demonstrates the safety of the platform on the long term.
  • When inclusion criteria are followed, there is no issue on endotheloim cell loss.
  • Posterior and iris-fixated phakic IOLs studys show simular loss of endothelium cells.

Patients selection

  • Artiplus is design to correct presbyopia for patients of 40-60 years old who are motivated to get rid of their (reading) glasses.
  • Phakic IOLs is extremely attractive type of surgery for myopia and presbyopia and can be considered instead of laser or CLE.
  • Young(er) myopic presbyops will not tollerate losing distance vision. Clear advantage of Artiplus compare to other solutions is the great distance vision.
  • For Post-lasik- and pseudophakic patients Artiplus offers good results as well.

Advantages Artiplus

  • High quality of vision at all distances.
  • One-size fits all (no issues with sizing).
  • Reversible procedure.
  • Perfect centration.
  • Extremely consistent results.
Discover all specs & features

A pretty big plus

Training and support

Need a refresher or want to get started with iris-fixated IOLs? We are here to help. Contact us for personal assistance.

Contact Tiago
Tiago - portret-1

Photo impression